The Kenya Biomaterials in Healthcare Market is expected to witness growth from $109 Mn in 2022 to $319 Mn in 2030 with a CAGR of 14.30% for the forecasted year 2022-2030. Many patients are traveling to Kenya for medical procedures, which is a growingly well-liked location for medical tourism. Since medical travellers frequently need high-quality medical equipment and supplies, this is anticipated to increase demand for biomaterials. The market is segmented by type and by application. Some key players in this market include: Omsai Distributors, Eurodent Supply, BASF SE, Johnson and Johnson, Philips Healthcare, Medtronic and Evonik Industries.
The Kenya Biomaterials in Healthcare Market size is at around $109 Mn in 2022 and is projected to reach $319 Mn in 2030, exhibiting a CAGR of 14.30% during the forecast period. From $3,188 Mn in 2016 to $3,476 Mn in 2020, Kenya's total health expenditures rose. In 2020, Kenya paid 6.3% of its GDP on health, down from 6.8% in 2014. In 2020, out-of-pocket costs accounted for 23.25% of Kenya's overall current health expenditures. As a percentage of Kenya's current health expenditures, out-of-pocket costs steadily dropped from 36.25% in 2015 to 23.25% in 2020.
Biomaterials are components used in the body to replace or enhance systems or tissues. They can be made of synthetic or natural materials and are commonly used in medical applications. Biomaterials are used to create implants, which can be used to replace missing or damaged body components like teeth, bones, joints, and joints. Biomaterials are used to create medical devices like pacemakers, tubes, and stents. Biomaterials can be used to distribute drugs. The medicine may be housed in an encapsulated form within the biomaterial that is implanted within the body. Biomaterials are used in tissue engineering to create new cells and organs for transplant. Biomaterials have no adverse effects on the body because they are safe. As a result, they are appropriate for use in medical environments. Each patient's needs can be met with a unique set of nanomaterials. They can therefore be precisely tailored to suit the body, improving the chances that surgeries will be successful. The restoration of harmed tissues and systems can benefit from biomaterials' capacity for promoting tissue regrowth. Biomaterials can be used for longer amounts of time than natural tissues because they outlive them.
Market Growth Drivers
Many patients are traveling to Kenya for medical procedures, which is a growingly well-liked location for medical tourism. Since medical travellers frequently need high-quality medical equipment and supplies, this is anticipated to increase demand for biomaterials. The increase in persistent ailments and life expectancy in Kenya are increasing demand for medical implants, such as dental implants, joint replacements, and spinal implants. This demand is expected to lead to a rise in the demand for the biomaterials used in medical devices. As people in Kenya become more aware of the importance of health and wellbeing, they are more apt to seek medical interventions to improve their quality of life. Due to the increased demand for medical prosthetics and equipment, the country's biomaterials industry is expected to grow. As a result of advancements in material science and technology, new biomaterials have been developed that are more durable, biocompatible, and helpful in medical applications. Manufacturers now have the opportunity to develop and market novel biomaterials that will meet the needs of the Kenyan healthcare industry.
Market Restraints
Kenya imports biomaterials frequently, which may result in higher prices and restricted supply. Customizing biomaterials for the local market is also hampered by limited local production. Kenya are becoming more conscious of healthcare, but they are still not as aware of biomaterials and their advantages. This may reduce the country's need for these resources.
Key Players
2022: In order to offer orthobiologics and regenerative medicine services, Lattice Biologics, a Canadian business that makes biomaterials, revealed a partnership with Sanitas Hospital in Nairobi, Kenya. With the help of the agreement, Sanitas Hospital will be able to provide patients with cutting-edge biomaterials treatment choices.
The Pharmacy and Poisons Act, which regulates the importation, production, distribution, and sale of biomaterials, serves as the legal foundation for Kenya's biomaterials regulatory system. The legislation mandates that the PPB be notified of the importation or manufacture of any biomaterials or medical devices in Kenya. Technical and clinical data must be submitted as part of the registration procedure for biomaterials to prove the products efficacy and safety. Before approving registration, the PPB reviews the data and may ask for more details or perform inspections of the manufacturing sites. The Kenya Bureau of Standards (KEBS), in addition to the PPB, is in charge of guaranteeing the security and caliber of biomaterials in Kenya. KEBS establishes biomaterials standards and performs inspections to verify adherence to those standards. Kenya's government has created laws to encourage the use of biomaterials in healthcare. For instance, the Kenya Health Policy 2014–2030 acknowledges the value of innovation and technology in healthcare and promotes the adoption of cutting-edge technologies, such as biomaterials, to enhance health results.
1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Type (Revenue, USD Billion):
Based on type, the market is segmented into Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, and Natural Biomaterials. The Metallic Biomaterials segment accounted for the largest share of the Kenya market in 2019. The growing geriatric population Kenyaly is expected to drive growth for this segment.
By Application (Revenue, USD Billion):
The cardiovascular, orthopaedic, dental, plastic surgery, wound healing, tissue engineering, ophthalmology, neurological/CNS, and other applications segments are made up of the biomaterials market. The market category for wound healing is anticipated to have the highest CAGR in 2019. The market will increase as a result of factors including expanding healthcare infrastructure, a large population pool, a rising diabetic population, and rising healthcare spending. Surgical Guides
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.